Ophthopedia’s Post

Ophthopedia Update:10-Year Clinical Outcomes of V4c Implantable Collamer Lens Implantation: Longitudinal Analysis of Visual Acuity, Endothelial Cell Density, and Vault Dynamics: This study aimed to evaluate the long-term clinical outcomes of V4c Implantable Collamer Lens (ICL) implantation for myopia correction over a 10-year period. #Ophthalmology #Ophthotwitter #Scicomm

Exciting news for AMD treatment! And further scientific evidence for the efficacy of photobiomodulation, or PBM. Want to know how light therapy works in the eye? Visit https://lnkd.in/gaVbKDRf To learn more about about the effects of AMD on vision, visit https://lnkd.in/gEcYAEjB #photobiomodulation #medicalanimation #scientificanimation #medicaldevice #amd #sciviz #lighttherapy #ophthalmology

Impressive results from the VENICE Trial - the FIRST Randomized Clinical Trial (RCT) in Canaloplasty, comparing STREAMLINE Canaloplasty to iStent W. Our interim findings show STREAMLINE Canaloplasty performs as well as iStent W in reducing IOP and medications when used alongside phacoemulsification. These are much needed data supporting the innovations in MIGS treatment options for Glaucoma! #glaucomaresearch #glaucoma #VENICEtrial https://lnkd.in/gDXwJazY

Get long-lasting Pain Relief with Radiofrequency Ablation. Radiofrequency ablation (RFA) is a minimally invasive procedure that uses heat to destroy targeted tissue. During the procedure, radiofrequency waves are transmitted through a precisely placed needle to generate localized heat surrounding targeted nerve fibers. This process effectively interrupts the transmission of pain signals to the brain, providing relief for qualifying patients. As an alternative to more extensive surgical interventions, RFA may offer lasting relief for people with chronic pain, especially in the lower back, neck, and arthritic joints. Find out if you're a candidate today- https://lnkd.in/eYPMgwC2

Proud to be an Author in this groundbreaking randomized controlled study (RCT). Interim results from the Venice RCT show STREAMLINE canaloplasty is as effective as iStent W in controlling IOP and reducing meds in primary open-angle Glaucoma. This marks a significant step forward in glaucoma management! #Glaucoma #Ophthalmologyinnovation https://lnkd.in/gaAZ9gFd

🌍🔬 At European Society of Retina Specialists (EURETINA) 2024, Dr. Tariq Aslam delves into the complexities of international healthcare systems and drug reimbursement strategies, highlighting how these vary dramatically across regions. From the use of biosimilars in the UK to the structured drug protocols in the Americas, Dr. Aslam shares his expert insights on navigating the diverse global landscape of ophthalmic care. 👁️💡 Explore the nuances of regional treatment options and the challenges clinicians face with drug approvals and usage protocols. Dr. Aslam's discussion sheds light on the critical need for clarity in drug usage, especially in treating conditions like AMD, diabetes, and vein occlusion. 🤝 Join us as we continue to bring you the latest discussions from leading experts at Euretina, ensuring you stay at the forefront of ophthalmology innovations and practices. #Euretina #Ophthalmology #EyeCare #RetinaSpecialist #MedicalInnovation #VisionHealth #EyeHealth #DigitalHealth #Retina #Ophthalmology #ClinicianLinkLive 

This study compares the anatomical and visual outcomes after vitrectomy with facedown (FD) or non-FD positions for treating myopic foveoschisis (MF) with foveal detachment in 55 eyes. They found that the non-FD position appeared to be as effective as the FD position after vitrectomy with fovea-sparing ILM peeling and air tamponade for treating MF with foveal detachment. Please read the full article here- Authors: Ke Zhu, Boya Lei, Fang Song, Rui Jiang, Qing Chang, Gezhi Xu Comparison of facedown and non-facedown positions after vitrectomy with fovea-sparing internal limiting membrane peeling and air tamponade for treating myopic foveoschisis with foveal detachment: A prospective, randomized interventional study. AJO International, Volume 1, Issue 2, 2024, 100036, ISSN 2950-2535 https://lnkd.in/gTfdTqYK

The global Colposcopy Devices Market is estimated to grow at a massive owing to the rising cases of cervical disorders, heightened awareness of early diagnosis, adoption of advanced technologies, and increased product launches. Some of the key companies in the Colonoscopy Devices Global Market include McKesson, ZEISS Group, Olympus Corporation of the Americas, MedGyn Products, Inc., DYSIS Medical, ATMOS MedizinTechnik GmbH & Co. KG, Ecleris México, OPTOMIC, Seiler Instrument & Mfg. Co. Inc., Karl Kaps, NARANG MEDICAL LIMITED, Hunan Fude Technology Co., Ltd., Kernel Medical Equipment Co.,Ltd, Delmont Imaging, Ateities biomedicinos fondas, Labdaros ir paramos fondas, and several others. Get a more detailed analysis, at: https://lnkd.in/gmbvB85i #colposcopy #cervicalhealth #womenshealth #medicaltechnology #gynecology #healthcareinnovation #earlydetection #medicaldevices #womenwellness #cervicalscreening #healthawareness #cancerprevention #medicaladvancements

𝗧𝗵𝗲 𝗣𝗼𝘄𝗲𝗿 𝗼𝗳 𝗮 𝗦𝗲𝗰𝗼𝗻𝗱 𝗢𝗽𝗶𝗻𝗶𝗼𝗻: 𝗪𝗵𝘆 𝗠𝗼𝗿𝗲 𝗘𝘆𝗲𝘀 𝗖𝗮𝗻 𝗟𝗲𝗮𝗱 𝘁𝗼 𝗕𝗲𝘁𝘁𝗲𝗿 𝗗𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 Ever wondered why some patients 𝙟𝙪𝙨𝙩 𝙙𝙤 𝙣𝙤𝙩 𝙜𝙚𝙩 𝙩𝙝𝙖𝙩 𝙞𝙣𝙟𝙚𝙘𝙩𝙞𝙤𝙣, even when the OCT shows fluid? Turns out, it is not always about what we see—but what we believe in. Our recent study took a closer look at this by having three Reading Centers (ＧＲＡＤＥ, ＣＩＲＣＬＥ, Ｍ３) review OCT images. The results? In everyday practice, fluid is missed more often than we would like to admit. And even when it’s spotted,  𝗶𝗻 𝗮 𝘁𝗵𝗶𝗿𝗱 𝗼𝗳 𝗰𝗮𝘀𝗲𝘀 treatment is skipped for diabetic macular oedema or oedema secondary to retinal vein occlusions. What is the reason? Sometimes, it is our own hesitation to act when we are not convinced ourselves. The classic excuse of “stable function” does not really cut it, especially when the potential for further improvement is right there! So, how do you tackle the tricky decision of "Treat of Not to Treat"? Many thanks to Georg Spital, Steffen Schmitz-Valckenberg, Bettina Müller, Erika Liczenczias, Petrus Chang, Britta Heimes‑Bussmann, and Sandra Liakopoulos the whole ORCA team! 𝗣𝗹𝗲𝗮𝘀𝗲 𝗿𝗲𝗮𝗱: Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study. Graefes Arch Clin Exp Ophthalmol. 2024 Sep 19. doi: 10.1007/s00417-024-06579-7. https://lnkd.in/ejt8_-Qi #4EyesPrinciple #Ophthalmology #RetinalDiseases #SecondOpinion #PatientCare #ClinicalDecisions

#Pterygium is a benign fibrovascular growth that extends from the conjunctiva to the corneal surface that can cause eye irritation, redness and impair vision. It most often affects people exposed to high levels of ultraviolet light or certain other environmental factors during outdoor work or leisure activities.      While there are no FDA-approved drugs for pterygium, Cloudbreak is developing the first potential therapy for this condition, which is now in Phase 3 clinical trials. Learn more about our work:  https://lnkd.in/e_UnxjTr